Journal of Laboratory Physicians
Home About us Ahead of print Current issue Back issues Subscribe Instructions Contact Login 
Wide layoutNarrow layoutPrint this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 


 
   Table of Contents     
CASE REPORT
Year : 2019  |  Volume : 11  |  Issue : 4  |  Page : 382-384  

A case of myelodysplastic syndrome with t(10;18)(q26;q21)


1 Department of Clinical Laboratory, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
2 Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Division of Blood Transfusion and Cell Therapy, Tohoku University Hospital, Sendai, Japan
3 Department of Cardiovascular Surgery, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
4 Department of Blood Transfusion; Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
5 Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
6 Department of Clinical Laboratory; Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

Date of Submission08-Apr-2019
Date of Acceptance22-Nov-2019
Date of Web Publication19-Dec-2019

Correspondence Address:
Prof. Shinichiro Takahashi
Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1, Fukumuro, Miyaginoku, Sendai 983-8536
Japan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JLP.JLP_61_19

Rights and Permissions
   Abstract 


An 82-year-old male was admitted. Pancytopenia, a slightly low white blood cell count (3400/μL), and low levels of red blood cells (2.65 × 106/μL), hemoglobin (10.4 g/dL), and platelets (118,000/μL) were observed. Bone marrow aspiration was performed, revealing hypocellular bone marrow and normal blast levels (0.6%) with no dysplasia. G-banding chromosome analysis revealed the karyotype 45,X,-Y[3]/45, idem, t(10;18)(q26;q21)[13]/46,XY[4]. The patient was diagnosed with myelodysplastic syndrome, unclassified (MDS–U). This is the first case report demonstrating a patient with the chromosomal translocation, t(14;18)(q32;q21), which is extremely rare. This chromosomal aberration was critical for the diagnosis of MDS in this patient.

Keywords: Chromosome banding, myelodysplastic syndromes, t(10;18)(q26;q21)


How to cite this article:
Ohba Y, Yamada-Fujiwara M, Minagawa T, Watanabe S, Okitsu Y, Izumi Y, Kameoka J, Takahashi S. A case of myelodysplastic syndrome with t(10;18)(q26;q21). J Lab Physicians 2019;11:382-4

How to cite this URL:
Ohba Y, Yamada-Fujiwara M, Minagawa T, Watanabe S, Okitsu Y, Izumi Y, Kameoka J, Takahashi S. A case of myelodysplastic syndrome with t(10;18)(q26;q21). J Lab Physicians [serial online] 2019 [cited 2020 Jan 18];11:382-4. Available from: http://www.jlponline.org/text.asp?2019/11/4/382/273559




   Introduction Top


In the WHO 2008 criteria revised in 2016, for a patient with clinical and other laboratory features, a presumptive diagnosis of myelodysplastic syndrome (MDS) can be made if a specific clonal chromosomal abnormality is present. The balanced abnormalities included in the 2008 criteria were t(11;16)(q23;p13.3), t(3;21)(q26.2;q22.1), t(1;3)(p36.3;q21.1), t(2;11)(p21;q23), inv (3)(q21q26.2), and t (6;9)(p23;q34),[1] while those further included in the 2016 criteria were t(5;12)(q32;p13.2), t(5;7)(q32;q11.2), t(5;17)(q32;p13.2), t(5;10)(q32;p21.2), and t(3;5)(q25.3;q35.1).[2] Recently, we encountered a patient with pancytopenia and what appears to be an extremely rare chromosomal abnormality, t(10;18)(q26;q21). As there was no obvious dysplasia or increase in blasts, we considered this reciprocal translocation as a “balanced abnormality” and diagnosed the patient with MDS, unclassified (MDS–U) according to the WHO classification system. The following case report further describes this chromosomal abnormality.


   Case Report Top


An 82-year-old male suffering from severe chest pain was taken by ambulance to a clinic. The day after, he received coronary angiography, and stenosis was observed in the right coronary artery. His chest pain persisted after angiography. Unstable angina was suspected, and the patient was transferred to the Cardiovascular Medicine Department at the Tohoku Medical and Pharmaceutical University Hospital to receive a percutaneous coronary intervention.

Upon admission to our hospital, the patient's white blood cell count was slightly low (3,400/μL), and low red blood cell (2.65 × 106/μL), hemoglobin (9.3 g/dL), and platelet(118,000/μL) levels were also observed [Table 1]. Echocardiography revealed severe aortic valve stenosis. Aortic valvuloplasty and coronary artery bypass graft surgery were performed. During the surgery, bone marrow aspiration from the sternum was performed. The aspiration was examined morphologically and cytogenetically. The patient's bone marrow was observed to be hypocellular with no obvious dysplasia [Figure 1]a and [Figure 1]b. The blast percentage was within the normal range at 0.6% [Figure 1]A and [Figure 1]B, and [Table 1]. G-banding analysis of the bone marrow sample revealed that the patient had a chromosomal translocation: among the 20 cells analyzed, three cells were karyotype A (45, X,-Y), 13 cells were karyotype B (45, idem, t(10;18)(q26;q21), and four cells were karyotype C (46, XY) [Figure 1]C. The patient was diagnosed with MDS–U. The patient remains carefully observed in our hospital as an outpatient thereafter.
Table 1: Laboratory findings at first visit and the result of bone marrow examination

Click here to view
Figure 1: Morphological images of bone marrow aspirations at the initial diagnosis using Wright–Giemsa staining and a result of G-banding chromosomal analysis. (A) Morphological image with × 100 magnification. Hypocellular marrow with lipid droplets was observed. (B) Image at × 1000 magnification. No apparent dysplasia was observed. (C) A G-banded karyotype showing 45, X,-Y[3]/45, idem, t(10;18)(q26;q21)[13]/46,XY[4]. Arrows indicate translocated regions

Click here to view



   Discussion Top


We recently reported the usefulness of careful histogram analysis of automatic blood cell analyzer results for acute leukemia, which assists with rapid morphological findings for blasts and abnormal cells.[3] However, not only morphologic but also cytogenetic studies are necessary to diagnose hematologic malignancies; this is common knowledge for clinical hematologists. A unique feature of the present case may be that the bone marrow aspiration and chromosome analysis were ordered and performed by cardiovascular surgeons rather than hematologists during the aortic valvuloplasty and coronary artery bypass graft surgery.

We speculate that the most likely gene playing a role in the pathogenesis of this patient's disease is BCL2. The BCL2 gene lies within 18q21.3 and is frequently translocated to the immunoglobulin heavy chain (IgH) gene enhancer region as a result of t(14;18)(q32;q21.3), which results in the over-expression of the BCL2 gene.[4] BCL2 overexpression is involved in the pathogenesis of follicular lymphoma by preventing apoptosis of the germinal center B-cells.[4] The t(14;18)(q32;q21.3) translocation can be detected by fluorescence in situ hybridization in 85% of all cases and is considered a molecular hallmark of this disease.

Not only follicular lymphoma but also several other hematopoietic malignancies are reported to be related to the aberrant expression of the BCL2 protein.[5] In particular, in MDS patients, BCL2 expression is high, while in aplastic anemia patients, BCL2 expression is low.[5] Previously, it was reported that progression to high-risk MDS correlates with elevated expression of BCL2 protein.[6] Collectively, BCL2 expression and regulation may affect the pathophysiology of MDS.

Chromosome 10 and 18 translocations are very rare. To the best of our knowledge, only four studies have reported such translocations.[7],[8],[9],[10] In particular, the breakpoint we observed, t(10;18)(q26;q21), was unique because it is not among these reported translocations. Although we could not identify what was fused with the gene residing in 18q21.3 (possibly the BCL2 gene), since this patient is too stable to perform further analysis, these results indicate that characterizing the gene (s) affected by this rare translocation may lead to further understanding of the biology of MDS.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009;114:937-51.  Back to cited text no. 1
    
2.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391-405.  Back to cited text no. 2
    
3.
Saito R, Yokoyama H, Meguro K, Ohba Y, Izumi Y, Takahashi S. Rapid diagnosis of mixed phenotype acute leukemia after identifying a blood histogram abnormality. Pract Lab Med 2018;12:e00101.  Back to cited text no. 3
    
4.
Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317:1185-9.  Back to cited text no. 4
    
5.
Mehta SV, Shukla SN, Vora HH. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: Its correlation with FLT3. Neoplasma 2013;60:666-75.  Back to cited text no. 5
    
6.
Invernizzi R, Pecci A, Bellotti L, Ascari E. Expression of p53, Bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes. Leuk Lymphoma 2001;42:481-9.  Back to cited text no. 6
    
7.
Tuck-Muller CM, Dyken PR, Li S, Chen H, Labbé E, Wertelecki W. Translocation 10;18 in a patient with juvenile neuronal ceroid-lipofuscinosis (Batten disease). Am J Med Genet 1995;57:168-71.  Back to cited text no. 7
    
8.
Gomi K, Hamanoue S, Tanaka M, Matsumoto M, Kitagawa N, Niwa T, et al. Anaplastic sarcoma of the kidney with chromosomal abnormality:First report on cytogenetic findings. Hum Pathol 2010;41:1495-9.  Back to cited text no. 8
    
9.
Rethoré MO, Prieur M, de Blois MC, Naffah J, Ravel A, Villain E, et al. Reciprocal syndromes caused by deficiency duplication resulting from maternal t(10;18)(p12;q22) translocation. Ann Genet 1985;28:149-53.  Back to cited text no. 9
    
10.
Forabosco A, Bernasconi S, Giovannelli G, Dutrillaux B. Trisomy of the distal third of the long arm of chromosome 10. Report of a new case due to a familial translocation t(10;18) (q24;p11). Helv Paediatr Acta 1975;30:289-95.  Back to cited text no. 10
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]



 

Top
 
 
  Search
 
  
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Case Report
   Discussion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed91    
    Printed6    
    Emailed0    
    PDF Downloaded11    
    Comments [Add]    

Recommend this journal